In recent years, numerous studies have shown that the cGAS-STING signaling pathway plays a pivotal role in the prevention and treatment of metabolic diseases, and this pathway may be a new target to combat metabolic diseases such as obesity and T2DM [2]. Here, STING1 is linked to obesity due to melanocortin 4 receptor deficiency.